Telesso
Technologies Wins Popular Science Invention Award for its Novel Peripheral IV
Catheter
SYDNEY, May 12, 2009 --Telesso
Technologies Limited (ASX: TEO), a global healthcare company, announced
today the FDA-approved guide wire-assisted peripheral IV catheter it is
developing with Vascular Pathways, Inc., has been honored with the Popular
Science Invention Award.
ÒTelesso is pleased to receive another
exciting external validation of this innovative device that may revolutionize
peripheral IV placement,Ó said TelessoÕs CEO Nelson K. Stacks. ÒAttempts to
start an IV frequently fail, which is frustrating for clinicians, painful for
patients and costly to the health care system. The new guide-wire assisted
peripheral IV catheter uses a practical design to improve the ability for
clinicians to get it right the first time, creating efficiency, enhancing
safety, reducing costs, and avoiding the need for re-sticks.Ó
A post-market trial is currently
comparing patients treated with TelessoÕs catheter to the industryÕs gold
standard device for peripheral IV placement. Data review is expected in Q2-Q3
2009.
About
the Guide Wire-Assisted Peripheral IV Catheter
A peripheral vein is the most common
site for insertion of a catheter for short-term diagnostic or therapeutic use.
The catheter is placed into the peripheral vein in the arm and is typically
passed up inside the vein to a length of 2-3 inches. TelessoÕs
uniquely-designed guide wire-assisted peripheral IV catheter device uses a
first-in-class retractable nitinol guide wire system that is believed to enable
easier IV access, reduce common safety risks, significantly lessen patient pain
and discomfort, and provide cost savings to facilities by lowering
administrative costs associated with failed IV starts. Telesso believes this
catheter device is the first clinically meaningful advancement in peripheral IV
access since automatic needle retraction catheters and addresses significant
unmet needs in peripheral intravenous access.
About
the Telesso-VPI Agreement
Telesso Technologies Limited announced
in December 2008 that it entered into a strategic agreement with Vascular
Pathways, Inc. (VPI), a private company based in California, to co-develop
VPIÕs guide wire-assisted device with the funding of the clinical trial and to
potentially acquire VPI.
For more information, visit TelessoÕs web site at http://www.telesso.com.
# # #
Contact:
Telesso Technologies
Ian Atkin, Chief Financial
Officer, Australia, +61 2 9805 0022, atkin@telesso.com
Jeff Riley, President,
USA, +1.619.309.7661, riley@telesso.com